S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
Clinical trial NCT02137837 · TERMINATED
Trial details
- NCT number
- NCT02137837
- Sponsor
- SWOG Cancer Research Network
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2019-12-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.